Background: CT perfusion (CTP) imaging is an important tool for identifying candidates for mechanical thrombectomy (MT). This modality is increasingly available in regional facilities, but whether pre-transfer perfusion imaging studies may be relied upon for treatment decisions is unclear. We analyzed a cohort of stroke transfers to quantify changes in CTP imaging profiles over time. Methods: A cohort of confirmed ischemic stroke patients who received CTP before and after transfer to a large mid-western comprehensive stroke center (CSC) were identified. We compared perfusion mismatch (MM), core infarct volume (CIV), and favorability of imaging for mechanical thrombectomy (MT) candidacy (defined as the presence of LVO and MM/CIV ratio of >1.8) between studies. Regression models were used to examine predictors of CIV growth including hypoperfusion intensity ratio (HIR) and time between studies. Results: Over a 24-month period, 61 patients met inclusion criteria. Median age was 71 (IQR 60-80), 52% were female, median NIHSS was 14 (IQR 4-19), and most patients had occlusion of the internal carotid and/or middle cerebral arteries (77%). The median time from last known well (LKW) to initial CT was 148 minutes (IQR 71-620) and median time between imaging studies was 149 minutes (IQR 126-194). Median CIV growth was 0 mL (IQR 0-6) and 8% (5/61) had growth ≥25 mL. In linear regression, higher HIR predicted CIV growth (β=24.3, p=0.04), but time from LKW to presentation and time between imaging studies did not. Imaging studies taken at the regional and CSC sites demonstrated excellent agreement in classifying patients as candidates for MT (kappa 0.778 [95% CI: 0.611-0.944]). A favorable regional CTP profile was 93% sensitive for MT delivery at the CSC with a positive predictive value of 63%. Conclusion: In our cohort, CIV growth between facilities was minimal despite relatively long interfacility transport times and was predicted by the regional HIR. A favorable regional imaging profile demonstrated high agreement with the imaging result at the CSC and was strongly associated with MT treatment.